| Target Molecule | Myristoyl Pentapeptide-17 |
| Synonyms | Myr-KLAKK-NH₂, SymPeptide 226EL, SymPeptide Xlash, N2-(1-Oxotetradecyl)-L-lysyl-L-leucyl-L-alanyl-L-lysyl-L-lysinamide |
| CAS Number | 959610-30-1 |
| Sequence (3-Letter) | Myristoyl-Lys-Leu-Ala-Lys-Lys-NH₂ |
| Sequence (1-Letter) | Myr-KLAKK-NH₂ |
| Molecular Formula | C₄₁H₈₁N₉O₆ |
| Molecular Weight | 796.16 |
| Service Category | Custom Synthesis / Cosmetic Peptide R&D |
| Synthesis Purity | Customizable (e.g., ≥95%, ≥98%, ≥99% by HPLC) |
| Appearance | White to off-white lyophilized powder |
| Counter Ion | Acetate (TFA-free available) or Custom Options |
| Synthesis Technology | Solid-Phase Peptide Synthesis (SPPS) |
| Modification Options | N-terminal lipid conjugations, C-terminal modifications, isotopic labeling |
| Available Scale | Milligram (R&D) to Kilogram (Commercial Manufacturing) |
| Analytical Data | Comprehensive COA, HPLC, MS provided per batch |
| Usage | Raw material synthesized strictly for laboratory research, cosmetic formulation R&D, and industrial manufacturing. Not a finished drug. |
Myristoyl Pentapeptide-17 (Myr-KLAKK-NH2, CAS 959610-30-1) is a synthetic lipopeptide featuring an N-terminal myristic acid cap and a C-terminal amide. We synthesize this specific target as a high-purity raw material for structural research and cosmetic formulation development.
We utilize optimized solid-phase peptide synthesis (SPPS). This platform ensures highly efficient amino acid coupling and precise control over deletion impurities, yielding batches that meet strict HPLC purity specifications.
Yes. The standard structure requires C-terminal amidation and N-terminal myristoylation with a C14 fatty acid. Our modification services can apply alternative lipid conjugates, targeted isotopic labels, or specific counter-ions to suit varying physical chemistry requirements.
Our infrastructure transitions seamlessly from milligram-scale laboratory batches to kilogram-scale commercial production. We maintain rigorous batch-to-batch consistency essential for industrial-scale formulation.
We serve as a strategic technical partner. Our team assists with sequence stability testing, impurity profiling, and the provision of complete analytical documentation to accelerate downstream formulation projects.
Myristoyl Pentapeptide-17, defined by the sequence Myr-KLAKK-NH2, is a synthetic lipopeptide frequently utilized in cosmetic formulation. Synpeptide provides comprehensive synthetic solutions for this target molecule, leveraging our technical expertise to support industrial formulation development and cosmetic R&D.
Through our established peptide synthesis platform, we achieve efficient coupling of the pentamer sequence via optimized Solid-Phase Peptide Synthesis (SPPS). We strictly control impurity profiles and sequence deletions during manufacturing, ensuring the final Myristoyl Pentapeptide-17 material meets exact purity specifications (routinely ≥98% via HPLC). This rigorous process control guarantees the batch-to-batch reproducibility required for both early-stage research and late-stage commercial formulation.
The baseline structure of Myristoyl Pentapeptide-17 requires specific lipid integration, specifically an N-terminal myristic acid (C14 fatty acid) cap and a C-terminal amide. Beyond these standard parameters, we offer extensive peptide modification services. Formulators can request specific counter-ion exchanges, alternate lipid conjugations to adjust solubility, or isotopic labeling for tracking studies. These structural adjustments enable researchers to precisely tune the molecule's physical properties for advanced delivery systems.
Scaling a lipopeptide from benchtop research to commercial application demands stable manufacturing protocols. We facilitate efficient large-scale peptide synthesis for Myristoyl Pentapeptide-17, managing the transition from milligram screening batches to kilogram-scale production. Our large-scale infrastructure ensures a continuous, reliable supply chain for global cosmetic manufacturers, supported by complete analytical documentation including COA, MS, and HPLC data for every delivered batch.
We function as a technical extension of our clients' teams, providing one-stop peptide formulation support. Our engineers assist clients in stability testing, degradation profiling, and identifying optimal handling conditions for Myristoyl Pentapeptide-17 in various matrices. By delivering precise analytical data alongside high-purity synthetic capacity, we enable R&D teams to execute complex formulation projects efficiently and confidently.
